The potentials of probiotics on gluten hydrolysis; a review study
- PMID: 33584998
- PMCID: PMC7881392
The potentials of probiotics on gluten hydrolysis; a review study
Abstract
Celiac disease (CD) is an autoimmune disorder of the small intestinal mucosa in genetically susceptible subjects consuming gluten. Gluten in wheat, rye and barley is harmful for some individuals and leads to various symptoms. Research has shown that treatment with probiotics in CD patients could improve the symptoms by the gluten hydrolysis. For this purpose, different databases such as Medline, PubMed, Scopus, and Google Scholar were searched using the following keywords: Celiac disease, Wheat flour, Gluten, glutamine, Probiotic, Bifidobacterium, Lactobacillus, Enzymes, Wheat allergy, Immune system, T cells, HLA-DQ2, HLA-DQ8, Gluten-free diet, Proteolysis, α2-gliadin fragment, Gliadin, 33-mer peptide, and Zonulin. The search aimed to retrieve the articles published during 2000-2019. Today, a gluten-free diet (GFD) is the only celiac disease treatment. Biotechnological strategy based on probiotic treatment could degrade gluten. Research has shown that combination of the probiotic enzyme is more effective than single probiotic on gluten hydrolysis. The result of different studies showed that probiotic mixture has the capacity to hydrolyze a considerable concentration of the 33-mer of gliadin completely. The present study was aimed to investigate associations between the capacities of probiotics on gluten hydrolysis.
Keywords: Celiac disease; Gliadin; Gluten-free diet; Probiotics; Wheat.
©2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases.
Figures
Similar articles
-
Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion.Appl Environ Microbiol. 2017 Jun 30;83(14):e00376-17. doi: 10.1128/AEM.00376-17. Print 2017 Jul 15. Appl Environ Microbiol. 2017. PMID: 28500039 Free PMC article.
-
VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue.Biochim Biophys Acta. 2006 Jan;1762(1):80-93. doi: 10.1016/j.bbadis.2005.09.008. Epub 2005 Oct 21. Biochim Biophys Acta. 2006. PMID: 16311022
-
A Probiotic Preparation Hydrolyzes Gliadin and Protects Intestinal Cells from the Toxicity of Pro-Inflammatory Peptides.Nutrients. 2020 Feb 14;12(2):495. doi: 10.3390/nu12020495. Nutrients. 2020. PMID: 32075195 Free PMC article.
-
Bacterial-Based Strategies to Hydrolyze Gluten Peptides and Protect Intestinal Mucosa.Front Immunol. 2020 Nov 3;11:567801. doi: 10.3389/fimmu.2020.567801. eCollection 2020. Front Immunol. 2020. PMID: 33224137 Free PMC article. Review.
-
Celiac disease: risk assessment, diagnosis, and monitoring.Mol Diagn Ther. 2008;12(5):289-98. doi: 10.1007/BF03256294. Mol Diagn Ther. 2008. PMID: 18803427 Review.
Cited by
-
The Gliadin Hydrolysis Capacity of B. longum, L. acidophilus, and L. plantarum and Their Protective Effects on Caco-2 Cells against Gliadin-Induced Inflammatory Responses.Nutrients. 2023 Jun 16;15(12):2769. doi: 10.3390/nu15122769. Nutrients. 2023. PMID: 37375673 Free PMC article.
-
Coeliac disease and microbiota: is it time for personalised biotics intervention? A scoping review.BMJ Nutr Prev Health. 2025 Mar 22;8(1):e001100. doi: 10.1136/bmjnph-2024-001100. eCollection 2025. BMJ Nutr Prev Health. 2025. PMID: 40771499 Free PMC article.
-
Intestinal permeability, food antigens and the microbiome: a multifaceted perspective.Front Allergy. 2025 Jan 9;5:1505834. doi: 10.3389/falgy.2024.1505834. eCollection 2024. Front Allergy. 2025. PMID: 39850945 Free PMC article. Review.
-
Assessment of salivary microbiota profile as a potential diagnostic tool for pediatric celiac disease.Sci Rep. 2024 Jul 19;14(1):16712. doi: 10.1038/s41598-024-67677-4. Sci Rep. 2024. PMID: 39030381 Free PMC article.
-
PROBIOTICS AS AN ADJUNCTIVE THERAPY FOR CELIAC DISEASE: SYMPTOM RELIEF AND QUALITY OF LIFE IMPROVEMENT.Arq Gastroenterol. 2025 Jul 21;62:e24111. doi: 10.1590/S0004-2803.24612024-111. eCollection 2025. Arq Gastroenterol. 2025. PMID: 40699044 Free PMC article. Clinical Trial.
References
-
- Ehsani-Ardakani MJ, Rostami-Nejad M, Villanacci V, Volta U, Manenti S, Caio G, et al. Gastrointestinal and Non-Gastrointestinal Presentation in Patients with Celiac Disease. Arch Iran Med. 2013;16:78–82. - PubMed
-
- Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–95. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous